Clinical Trial Update: SURPASS Impella 5.5 Study

View source ↗

Summary

Clinical trial update for the SURPASS Impella 5.5 study sponsored by Abiomed; the study addresses cardiogenic shock and acute decompensated heart failure and is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Decompensated Heart Failure

Drugs mentioned

• Impella 5.5 (Impella 5.5 ventricular assist device)

Snippet

Sponsor: Abiomed Inc. | Conditions: Cardiogenic Shock, Acute Decompensated Heart Failure | Status: COMPLETED